Similar articles

• Structured interruptions of therapy: looking for the best protocol.

  Aiuti F, Giovannetti A. Aiuti F, et al. AIDS. 2003 Oct 17;17(15):2257-8. doi: 10.1097/01.aids.0000088240.55968.2c. AIDS. 2003. PMID: 14523284 No abstract available.
• Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.

  Nuesch R, Ananworanich J, Sirivichayakul S, Ubolyam S, Siangphoe U, Hill A, Cooper D, Lange J, Phanuphak P, Ruxrungtham K. Nuesch R, et al. Clin Infect Dis. 2005 Mar 1;40(5):728-34. doi: 10.1086/427878. Epub 2005 Feb 4. Clin Infect Dis. 2005. PMID: 15714420 Clinical Trial.
• A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.

  Fagard C, Oxenius A, Günthard H, Garcia F, Le Braz M, Mestre G, Battegay M, Furrer H, Vernazza P, Bernasconi E, Telenti A, Weber R, Leduc D, Yerly S, Price D, Dawson SJ, Klimkait T, Perneger TV, McLean A, Clotet B, Gatell JM, Perrin L, Plana M, Phillips R, Hirschel B; Swiss HIV Cohort Study. Fagard C, et al. Arch Intern Med. 2003 May 26;163(10):1220-6. doi: 10.1001/archinte.163.10.1220. Arch Intern Med. 2003. PMID: 12767960
• Dynamics and evolution of HIV-1 during structured treatment interruptions.

  Frost SD. Frost SD. AIDS Rev. 2002 Jul-Sep;4(3):119-27. AIDS Rev. 2002. PMID: 12416446 Review.
• [Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].

  Halota W, Pawłowska M. Halota W, et al. Przegl Epidemiol. 2002;56 Suppl 5:41-5. Przegl Epidemiol. 2002. PMID: 15553071 Review. Polish.